abstract |
HCV replication inhibitors having formula (I) and N-oxides, salts or stereoisomers thereof; pharmaceutical compositions containing formula (I) and processes for preparing compound (I). Also provided are bioavailable combinations of HCV inhibitors of a compound of formula (I) and ritonavir. |